[Translation] A single-center, randomized, open-label, single-dose, two-formulation, two-period, two-sequence, self-crossover bioequivalence study of idecalciferol soft capsules (0.75 μg) in healthy subjects under fasting and fed conditions
主要目的:以北京斯利安药业有限公司提供的艾地骨化醇软胶囊(规格:0.75μg)为受试制剂,原研Chugai Pharmaceutical Co.,Ltd持证的艾地骨化醇软胶囊(规格:0.75μg,商品名:Edirol®)为参比制剂,在空腹和餐后状态下评价受试制剂同参比制剂的生物等效性。
次要目的:观察空腹和餐后状态下受试制剂艾地骨化醇软胶囊和参比制剂艾地骨化醇软胶囊(Edirol®)在健康受试者中的安全性。
[Translation] Primary objective: To evaluate the bioequivalence of the test preparation with the reference preparation under fasting and postprandial conditions, using the edicalcitol soft capsules (specification: 0.75μg) provided by Beijing Silian Pharmaceutical Co., Ltd. as the test preparation and the edicalcitol soft capsules (specification: 0.75μg, trade name: Edirol®) certified by Chugai Pharmaceutical Co., Ltd. as the reference preparation.
Secondary objective: To observe the safety of the test preparation edicalcitol soft capsules and the reference preparation edicalcitol soft capsules (Edirol®) in healthy subjects under fasting and postprandial conditions.